125 related articles for article (PubMed ID: 7109625)
1. In vivo delayed hypersensitivity reactions to partially purified human melanoma antigens.
Sutherland CM; Leong SP; Cooperband SR; Deckers PJ; Hornung MO; Krementz ET
J Surg Oncol; 1982 Aug; 20(4):221-6. PubMed ID: 7109625
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
3. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
4. [Immunology of malignant melanoma].
Misgeld V
Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
[No Abstract] [Full Text] [Related]
5. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
6. [State of the stroma in melanoma in patients with different delayed hypersensitivity reaction to neoplasm antigen].
Lavnikova GA; Voronina EA; Babakova SV
Vopr Onkol; 1978; 24(11):24-30. PubMed ID: 741696
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells.
Fass L; Herberman RB; Ziegler JL; Kiryabwire JW
Lancet; 1970 Jan; 1(7638):116-8. PubMed ID: 4188725
[No Abstract] [Full Text] [Related]
8. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
9. Adoptive transfer and specific active immunization of patients with malignant melanoma.
Seigler H; Buckley CE; Sheppard LB; Horne BJ; Shingleton WW
Ann N Y Acad Sci; 1976; 277(00):522-32. PubMed ID: 1069561
[No Abstract] [Full Text] [Related]
10. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in patients with melanoma.
Seiger HF; Shingleton WW; Metzgar RS; Buckley CE
Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702
[No Abstract] [Full Text] [Related]
12. [Delayed hypersensitivity reaction in malignant melanoma].
Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
[No Abstract] [Full Text] [Related]
13. Immunogenicity and tumor protective activity of B16 melanoma vaccines.
Johnston D; Bystryn JC
Mol Biother; 1989; 1(4):218-22. PubMed ID: 2818873
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F
Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169
[TBL] [Abstract][Full Text] [Related]
15. Human tumor antigens inducing in vivo delayed hypersensitivity and in vitro mitogenic activity.
Tarro G; Pederzini A; Flaminio G; Maturo S
Oncology; 1983; 40(4):248-54. PubMed ID: 6866421
[TBL] [Abstract][Full Text] [Related]
16. Active-specific immunotherapy for melanoma.
Mitchell MS; Harel W; Kempf RA; Hu E; Kan-Mitchell J; Boswell WD; Dean G; Stevenson L
J Clin Oncol; 1990 May; 8(5):856-69. PubMed ID: 2139701
[TBL] [Abstract][Full Text] [Related]
17. Serological detection of common human melanoma membrane antigens by microcomplement fixation and immunofluorescence.
Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Fried RM; Krementz ET
Oncology; 1983; 40(2):95-101. PubMed ID: 6338430
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a soluble tumor-associated antigen from human melanoma.
Roth JA; Holmes EC; Reisfeld RA; Slocum HK; Morton DL
Cancer; 1976 Jan; 37(1):104-10. PubMed ID: 1247946
[TBL] [Abstract][Full Text] [Related]
19. Detection of tumor-associated antigen in human melanoma cell line supernatants.
Grimm EA; Silver HK; Roth JA; Chee DO; Gupta RK; Morton DL
Int J Cancer; 1976 May; 17(5):559-64. PubMed ID: 1270174
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
